Key result
Human umbilical cord mesenchymal stem cell-derived exosomes alleviated CVB3-induced myocarditis by activating the AMPK/mTOR-mediated autophagy flux pathway to attenuate cardiomyocyte apoptosis.
Why the study?
Human umbilical cord mesenchymal stem cell-derived exosomes show potential for tissue repair, but their effects on coxsackievirus B3-induced myocarditis remained unknown.
Do hucMSC-exosomes alleviate CVB3-induced myocarditis in preclinical models?
Do hucMSC-exosomes alleviate CVB3-induced myocarditis in preclinical models?
hucMSC-exosomes alleviate CVB3-induced myocarditis in preclinical models by activating the AMPK/mTOR-mediated autophagy flux pathway to attenuate cardiomyocyte apoptosis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for hucMSC-exosome therapy in viral myocarditis; human trials required before any clinical consideration.
Human umbilical cord mesenchymal stem cell-derived exosomes (hucMSC-exosomes) have been implicated as a novel therapeutic approach for tissue injury repair and regeneration, but the effects of hucMSC-exosomes on coxsackievirus B3 (CVB3)-induced myocarditis remain unknown. The object of the present study is to investigate whether hucMSC-exosomes have therapeutic effects on CVB3-induced myocarditis (VMC). HucMSC-exosomes were identified using nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM) and Western blot. The purified hucMSC-exosomes tagged with PKH26 were tail intravenously injected into VMC model mice in vivo and used to administrate CVB3-infected human cardiomyocytes (HCMs) in vitro, respectively. The effects of hucMSC-exosomes on myocardial pathology injury, proinflammatory cytokines and cardiac function were evaluated through haematoxylin and eosin (H&E) staining, quantitative polymerase chain reaction (qPCR) and Doppler echocardiography. The anti-apoptosis role and potential mechanism of hucMSC-exosomes were explored using TUNEL staining, flow cytometry, immunohistochemistry, Ad-mRFP-GFP-LC3 transduction and Western blot. In vivo results showed that hucMSC-exosomes (50 μg iv) significantly alleviated myocardium injury, shrank the production of proinflammatory cytokines and improved cardiac function. Moreover, in vitro data showed that hucMSC-exosomes (50 μg/mL) inhibited the apoptosis of CVB3-infected HCM through increasing pAMPK/AMPK ratio and up-regulating autophagy proteins LC3II/I, BECLIN-1 and anti-apoptosis protein BCL-2 as well as decreasing pmTOR/mTOR ratio, promoting the degradation of autophagy flux protein P62 and down-regulating apoptosis protein BAX. In conclusion, hucMSC-exosomes could alleviate CVB3-induced myocarditis via activating AMPK/mTOR-mediated autophagy flux pathway to attenuate cardiomyocyte apoptosis, which will be benefit for MSC-exosome therapy of myocarditis in the future.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2020) studied Coxsackievirus B3 (CVB3)-induced myocarditis. Human umbilical cord mesenchymal stem cell-derived exosomes (hucMSC-exosomes) was evaluated on Myocardial pathology injury, proinflammatory cytokines, cardiac function, and apoptosis. Human umbilical cord mesenchymal stem cell-derived exosomes alleviated CVB3-induced myocarditis by activating the AMPK/mTOR-mediated autophagy flux pathway to attenuate cardiomyocyte apoptosis.
Synapse has enriched 10 related papers. Consider them for comparative context: